Compile Data Set for Download or QSAR
maximum 50k data
Found 119 with Last Name = 'terasaka' and Initial = 't'
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22925((8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxol...)
Affinity DataKi:  0.0330nM ΔG°:  -59.2kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMedDrugBank

TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22947(1-[(2R)-4-{5-[3-(4-chlorophenyl)propoxy]-1-methyl-...)
Affinity DataKi:  4.90nM ΔG°:  -47.0kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22937(1-[(2R)-4-{6-[(benzylcarbamoyl)amino]-1H-indol-1-y...)
Affinity DataKi:  7.5nM ΔG°:  -45.9kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22920(1-[(2R)-1-hydroxy-4-{6-[3-(1-methyl-1H-1,3-benzodi...)
Affinity DataKi:  7.70nM ΔG°:  -45.8kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22920(1-[(2R)-1-hydroxy-4-{6-[3-(1-methyl-1H-1,3-benzodi...)
Affinity DataKi:  7.70nM ΔG°:  -45.8kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22920(1-[(2R)-1-hydroxy-4-{6-[3-(1-methyl-1H-1,3-benzodi...)
Affinity DataKi:  7.70nM ΔG°:  -45.8kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22950(1-[(3R,4S)-4-hydroxy-1-(naphthalen-2-yloxy)pentan-...)
Affinity DataKi:  9.80nM ΔG°:  -45.3kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22931(1-[(2R)-1-hydroxy-4-[6-(5-phenylpentanamido)-1H-in...)
Affinity DataKi:  11nM ΔG°:  -45.0kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22948(1-[(1R,2S)-2-hydroxy-1-(2-naphthalen-1-ylethyl)pro...)
Affinity DataKi:  11nM ΔG°:  -45.0kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22939(1-[(2R)-1-hydroxy-4-[6-(4-phenylbutoxy)-1H-indol-1...)
Affinity DataKi:  12nM ΔG°:  -44.8kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22946(1-[(2R)-4-[5-(hexyloxy)-1-methyl-1H-indol-3-yl]-1-...)
Affinity DataKi:  13nM ΔG°:  -44.6kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22949(1-[(3R,4S)-1-(2,3-dichlorophenyl)-4-hydroxypentan-...)
Affinity DataKi:  13nM ΔG°:  -44.6kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22942(1-[(2R)-4-{6-[3-(4-chlorophenyl)propoxy]-1H-indol-...)
Affinity DataKi:  13nM ΔG°:  -44.6kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22930(1-[(2R)-1-hydroxy-4-[6-(4-phenylbutanamido)-1H-ind...)
Affinity DataKi:  16nM ΔG°:  -44.0kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22936(1-[(2R)-1-hydroxy-4-{6-[3-(pyridin-3-yl)propanamid...)
Affinity DataKi:  17nM ΔG°:  -43.9kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22938(1-[(2R)-1-hydroxy-4-[6-(3-phenylpropoxy)-1H-indol-...)
Affinity DataKi:  17nM ΔG°:  -43.9kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22928(1-[(2R)-4-(6-hexanamido-1H-indol-1-yl)-1-hydroxybu...)
Affinity DataKi:  24nM ΔG°:  -43.1kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22945(1-[(2R)-1-hydroxy-4-[1-methyl-5-(3-phenylpropoxy)-...)
Affinity DataKi:  26nM ΔG°:  -42.9kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22929(1-[(2R)-1-hydroxy-4-[6-(3-phenylpropanamido)-1H-in...)
Affinity DataKi:  30nM ΔG°:  -42.5kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22935(1-[(2R)-1-hydroxy-4-{6-[4-(4-methylphenyl)butanami...)
Affinity DataKi:  34nM ΔG°:  -42.2kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22926(3-(6-amino-9H-purin-9-yl)nonan-2-ol | EHNA | Eryth...)
Affinity DataKi:  37nM ΔG°:  -42.0kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22933(1-[(2R)-1-hydroxy-4-{6-[3-(4-methylphenyl)propanam...)
Affinity DataKi:  38nM ΔG°:  -41.9kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22940(1-[(2R)-4-[6-(hexyloxy)-1H-indol-1-yl]-1-hydroxybu...)
Affinity DataKi:  55nM ΔG°:  -41.0kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22934(1-[(2R)-1-hydroxy-4-{6-[3-(4-methoxyphenyl)propana...)
Affinity DataKi:  57nM ΔG°:  -40.9kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22932(1-[(2R)-1-hydroxy-4-[6-(6-phenylhexanamido)-1H-ind...)
Affinity DataKi:  91nM ΔG°:  -39.8kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22941(1-[(2R)-4-(6-butoxy-1H-indol-1-yl)-1-hydroxybutan-...)
Affinity DataKi:  240nM ΔG°:  -37.4kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22919(1-[1-hydroxy-4-(naphthalen-1-yl)butan-2-yl]-1H-imi...)
Affinity DataKi:  680nM ΔG°:  -34.8kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22918(2-(4-{5-[(1H-1,3-benzodiazol-2-ylamino)methyl]thio...)
Affinity DataKi:  1.20E+3nM ΔG°:  -33.5kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22927(1-[(2R)-4-(6-acetamido-1H-indol-1-yl)-1-hydroxybut...)
Affinity DataKi:  1.30E+3nM ΔG°:  -33.3kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22943(1-[(2R)-1-hydroxy-4-[5-(3-phenylpropoxy)-1H-indol-...)
Affinity DataKi:  1.90E+3nM ΔG°:  -32.3kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22917(1-(1-hydroxy-4-phenylbutan-2-yl)-1H-imidazole-4-ca...)
Affinity DataKi:  5.90E+3nM ΔG°:  -29.5kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22917(1-(1-hydroxy-4-phenylbutan-2-yl)-1H-imidazole-4-ca...)
Affinity DataKi:  5.90E+3nM ΔG°:  -29.5kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22944(1-[(2R)-4-[5-(hexyloxy)-1H-indol-1-yl]-1-hydroxybu...)
Affinity DataKi:  6.20E+3nM ΔG°:  -29.4kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22921(1-(2-hydroxy-1-phenylethyl)-1H-imidazole-4-carboxa...)
Affinity DataKi:  5.40E+4nM ΔG°:  -24.1kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22922(1-(2-hydroxy-1-phenylethyl)-1H-imidazole-4-carboxy...)
Affinity DataKi: >1.00E+5nM ΔG°: >-22.6kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22924(2-[4-(hydroxymethyl)-1H-imidazol-1-yl]-2-phenyleth...)
Affinity DataKi: >1.00E+5nM ΔG°: >-22.6kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22923(imidazole-4-carboxylate compound, 5 | methyl 1-(2-...)
Affinity DataKi: >1.00E+5nM ΔG°: >-22.6kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFibroblast growth factor receptor 1(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50593531(ASP-5878 | ASP5878 | Asp 5878 | Asp-5878 | Asp5878)
Affinity DataIC50:  0.470nMAssay Description:Inhibition of FGFR1 (unknown origin) in presence of ATP at Km concentration by mobility shift assayMore data for this Ligand-Target Pair
In DepthDetails PubMed
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50593531(ASP-5878 | ASP5878 | Asp 5878 | Asp-5878 | Asp5878)
Affinity DataIC50:  0.600nMAssay Description:Inhibition of FGFR2 (unknown origin) in presence of ATP at Km concentration by mobility shift assayMore data for this Ligand-Target Pair
In DepthDetails PubMed
TargetFibroblast growth factor receptor 3(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50593524(CHEMBL5206147)
Affinity DataIC50: <1nMAssay Description:Inhibition of wild type N-terminal GST tagged FGFR3 (436 to 806 residues) (unknown origin) expressed in sf21 insect cells preincubated for 30 mins fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetFibroblast growth factor receptor 3(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50593522(CHEMBL5170802)
Affinity DataIC50:  1.10nMAssay Description:Inhibition of wild type N-terminal GST tagged FGFR3 (436 to 806 residues) (unknown origin) expressed in sf21 insect cells preincubated for 30 mins fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetFibroblast growth factor receptor 3(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50593525(CHEMBL5182060)
Affinity DataIC50:  1.10nMAssay Description:Inhibition of wild type N-terminal GST tagged FGFR3 (436 to 806 residues) (unknown origin) expressed in sf21 insect cells preincubated for 30 mins fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetFibroblast growth factor receptor 3(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50593521(CHEMBL5182779)
Affinity DataIC50:  1.10nMAssay Description:Inhibition of wild type N-terminal GST tagged FGFR3 (436 to 806 residues) (unknown origin) expressed in sf21 insect cells preincubated for 30 mins fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetFibroblast growth factor receptor 3(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50559408(CHEMBL4763773)
Affinity DataIC50:  1.20nMAssay Description:Inhibition of human N-terminal GST-tagged FGFR3 (436 to end residues) expressed in baculovirus expression system using CSKtide as substrate incubated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetFibroblast growth factor receptor 3(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50593530(CHEMBL5201061)
Affinity DataIC50:  1.20nMAssay Description:Inhibition of wild type N-terminal GST tagged FGFR3 (436 to 806 residues) (unknown origin) expressed in sf21 insect cells preincubated for 30 mins fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50559408(CHEMBL4763773)
Affinity DataIC50:  1.20nMAssay Description:Inhibition of human N-terminal GST-tagged FGFR2 (399 to end residues) expressed in baculovirus expression system using CSKtide as substrate incubated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetFibroblast growth factor receptor 3(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50593526(CHEMBL5197399)
Affinity DataIC50:  1.30nMAssay Description:Inhibition of wild type N-terminal GST tagged FGFR3 (436 to 806 residues) (unknown origin) expressed in sf21 insect cells preincubated for 30 mins fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetFibroblast growth factor receptor 3(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50593520(CHEMBL5194555)
Affinity DataIC50:  1.40nMAssay Description:Inhibition of wild type N-terminal GST tagged FGFR3 (436 to 806 residues) (unknown origin) expressed in sf21 insect cells preincubated for 30 mins fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetFibroblast growth factor receptor 3(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50593532(CHEMBL5193271)
Affinity DataIC50:  1.5nMAssay Description:Inhibition of wild type N-terminal GST tagged FGFR3 (436 to 806 residues) (unknown origin) expressed in sf21 insect cells preincubated for 30 mins fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetFibroblast growth factor receptor 3(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50559406(CHEMBL4746045)
Affinity DataIC50:  1.60nMAssay Description:Inhibition of human N-terminal GST-tagged FGFR3 (436 to end residues) expressed in baculovirus expression system using CSKtide as substrate incubated...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 119 total ) | Next | Last >>
Jump to: